Harte-Hanks (NYSE: HHS) reported Q4 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $121.2 million versus the consensus estimate of $130.53 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.